Download Sample, Rising Use of Disposable IV Therapy Products in Healthcare Facilities
With the increasing use of disposable IV treatment items in healthcare institutions and ongoing technical developments, significant growth in the market is expected in the upcoming years. Due to factors such as the rising number of surgical procedures, the high prevalence of chronic diseases, and the increased focus on infection prevention measures, the global market for disposable IV treatment supplies is expected to rise rapidly. According to the National Institute of Health (NIH), chronic illnesses will account for 82% of global fatalities by 2024. The growing use of disposable IV treatment products in healthcare facilities is one of the main drivers of market expansion.
The market is expanding as a result of factors like simple access, affordable IV fluid bags, and an increase in the prevalence of chronic diseases like diabetes and cancer among the older population. 2023 saw an estimated 21.1 million new instances of cancer reported globally, according to the World Health Organization. Approximately 21% of India's senior population has at least one chronic condition, according to National Centre for Biotechnology Information (NCBI) data. The rising rate of chronic illness and the subsequent increase in hospital admission which raise the risk of healthcare-associated infections, are factors in the industry's robust performance through 2032.
The market is expanding as a result of factors like simple access, affordable IV fluid bags, and an increase in the prevalence of chronic diseases like diabetes and cancer among the older population. 2023 saw an estimated 21.1 million new instances of cancer reported globally, according to the World Health Organization. Approximately 21% of India's senior population has at least one chronic condition, according to National Centre for Biotechnology Information (NCBI) data. The rising rate of chronic illness and the subsequent increase in hospital admission which raise the risk of healthcare-associated infections, are factors in the industry's robust performance through 2032.
New Innovation and Technological Advancement Act as the Market Dynamics
The market players are expected to benefit from the growing technological advancements in IV equipment in the forecast period. Recent technological advancements consist of needle-free ports, smart pumps, portable IV devices, wireless and remote monitoring, nanotechnology, and more. These developments could enhance the efficacy, security, and productivity of IV treatment. These factors are expected to generate profitable opportunities for market players in the future. Improvements in drug delivery methods improve the effectiveness, accuracy, and safety of giving intravenous solutions. The market's growth is aided by advancements like smart infusion pumps and nanotechnology-based carriers which address issues like dosage control and targeted drug delivery.
The use of intravenous infusion systems to deliver medication, amino acids, minerals, and various important micronutrients can contribute to the growth of the infusion system market by enhancing nutritional support. Smart infusion systems have advanced technology including automation, drug libraries, operators, and safety features to provide precise and accurate results for patients, as well as delivering controlled fluids into patient systems. In September 2023, Rocialle Healthcare is presenting a new line of integrated IV cannulas with a closed system and a needle-stick prevention feature to reduce infection risks and minimize catheter manipulation, as reported by the clinical services journal.
The use of intravenous infusion systems to deliver medication, amino acids, minerals, and various important micronutrients can contribute to the growth of the infusion system market by enhancing nutritional support. Smart infusion systems have advanced technology including automation, drug libraries, operators, and safety features to provide precise and accurate results for patients, as well as delivering controlled fluids into patient systems. In September 2023, Rocialle Healthcare is presenting a new line of integrated IV cannulas with a closed system and a needle-stick prevention feature to reduce infection risks and minimize catheter manipulation, as reported by the clinical services journal.
Recent Trends in the Disposable Intravenous Products Industry
- Rising focus on sterile and disposable IV products to reduce the chances of infections.
- Advancement of new materials that provide enhanced biocompatibility.
- Implementing sustainable to minimize harm on the environment.
- Increasing need for personalized intravenous solution for individual patient.
- Ensuring product safety and efficacy through compliance with regulations and standards.
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
Stringent Government Regulation is Primary Factor that Hindering the Market Expansion
Improper disposing of infusion pumps and increasing patient safety worries may result in numerous repercussions and unmet medical needs in developing countries, which could hinder the expansion of the worldwide infusion system market. Stringent government regulations for approving new devices are the primary factor hindering the infusion systems market from 2022 to 2025. Additionally, the U.S. Food and Drug Administration has sent a communication to infusion system manufacturers detailing issues with the controlled-release infusion system that are hindering the expansion of the worldwide infusion system market.
A recall of a product is creating significant issues for the sector, ultimately impacting the entire market. After finding midazolam residues, B. Braun Medical Limited is recalling multiple product batches in July as a safety measure. In September 2023, Medline Industries is recalling the non-sterile Hudson RCI Addipak Unit Dose Vial containing 0.9% Full Normal Saline Solution due to lack of sterility. Because they could potentially be too potent, Leiters Health is pulling back 23,000 IV fentanyl citrate packets in the United States. As per the FDA Enforcement Report dated February 7, 2024, there is a possibility that IV bags may have double the recommended dosage.
A recall of a product is creating significant issues for the sector, ultimately impacting the entire market. After finding midazolam residues, B. Braun Medical Limited is recalling multiple product batches in July as a safety measure. In September 2023, Medline Industries is recalling the non-sterile Hudson RCI Addipak Unit Dose Vial containing 0.9% Full Normal Saline Solution due to lack of sterility. Because they could potentially be too potent, Leiters Health is pulling back 23,000 IV fentanyl citrate packets in the United States. As per the FDA Enforcement Report dated February 7, 2024, there is a possibility that IV bags may have double the recommended dosage.
Leading-Edge Companies in Infusion Therapies and Technologies are Driving Remarkable Advancements in the Market
IV products have seen impressive progress lately, fuelled by new technologies and creative methods. These breakthroughs are transforming the intravenous treatment sector, elevating patient care, and enhancing healthcare distribution. For instance, in May 2024, the Serum Institute of India (SII), known as the biggest vaccine producer globally, revealed a strategic investment in IntegriMedical by buying a 20% ownership in the firm to promote Needle-Free Injection System technology. The collaboration between SII and IntegriMedical supports SII's goal of 'Health for All' and IntegriMedical's aim to ‘Transform Healthcare Globally’ through improving patient comfort, promoting better patient compliance, decreasing needle-stick injuries, and boosting the effectiveness of liquid medication with needle-free dispersion.
Other medical equipment products like syringes and needles have established methods for post-use collection, while non-hazardous IV bag removal involves draining residual fluid and disposing of it as waste that eventually goes to a landfill. During this trial program, participants from various departments at North-Western Memorial Hospital, such as nursing, supply chain, and environmental services, collaborated to create a new process. This process allows for material separation for recycling to be integrated into nursing workflows while also addressing space limitations typically found in hospital settings. For instance, In December 2023, Baxter launched an initial IV bag recycling program for American hospitals.
Other medical equipment products like syringes and needles have established methods for post-use collection, while non-hazardous IV bag removal involves draining residual fluid and disposing of it as waste that eventually goes to a landfill. During this trial program, participants from various departments at North-Western Memorial Hospital, such as nursing, supply chain, and environmental services, collaborated to create a new process. This process allows for material separation for recycling to be integrated into nursing workflows while also addressing space limitations typically found in hospital settings. For instance, In December 2023, Baxter launched an initial IV bag recycling program for American hospitals.
Searching for a Country or Region Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
Europe and the Asia-Pacific Region Play a Significant Role in the Field of Infusion Therapy
Europe holds the alternate largest request for intravenous results encyclopaedically, with the deal volume adding in response to the region's growing senior population and the corresponding expansion of the patient base. The reason for this is due to the healthcare system having a large number of cases, prominent crucial players, accessible medicines, advanced healthcare systems, and favorable payment programs. Also, the growth of the European intravenous results request is anticipated to be fuelled by advancing technology in the sector and support from the government for the National Health Service and health insurance. Furthermore, the UK IV result request dominated the request share, while the IV result request in France saw the quickest growth in Europe.
In Asia Pacific, due to the growing prevalence of chronic diseases caused by unhealthy eating habits and the rising demand for easily available healthcare, the Asia Pacific market is expected to rise at a quicker rate. The Asia Pacific area's old population is predicted to increase rapidly by 2030, there will be 1.4 billion people in the region, who are 70 years of age or older. As of the rise in chronic conditions including diabetes, heart disease, and cancer, this group is more likely to require IV therapy.
In Asia Pacific, due to the growing prevalence of chronic diseases caused by unhealthy eating habits and the rising demand for easily available healthcare, the Asia Pacific market is expected to rise at a quicker rate. The Asia Pacific area's old population is predicted to increase rapidly by 2030, there will be 1.4 billion people in the region, who are 70 years of age or older. As of the rise in chronic conditions including diabetes, heart disease, and cancer, this group is more likely to require IV therapy.
The report provides a detailed overview of the disposable intravenous products market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for disposable intravenous products market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the disposable intravenous products market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the disposable intravenous products market. Some key country and region included in the disposable intravenous products market report as follows:
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Disposable Intravenous Product Market Research Report Covers In-depth Analysis on:
- Disposable intravenous products market detailed segments and segment-wise market breakdown
- Disposable intravenous products market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in disposable intravenous products industry)
- Current, historical, and forthcoming 10 years market valuation in terms of disposable intravenous products market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Disposable intravenous products market demand analysis
- Disposable intravenous products market pricing analysis over the forecast period (by key segment and by region)
- Disposable intravenous products market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in disposable intravenous products market
- Regulatory landscape by key regions and key countries
- Supply chain and value chain analysis in the disposable intravenous products market
- Disposable intravenous products market sales and distribution strategies
- A comprehensive overview of the parent market
- A detailed viewpoint on the disposable intravenous products market forecast by countries
- Mergers and acquisitions in the disposable intravenous products market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What are the key drivers influencing the growth of the disposable intravenous products market?
The market is driven by increasing demand for cost-effective medical supplies, advancements in healthcare infrastructure, and rising awareness of infection control measures among healthcare providers globally.
What are the major challenges faced by the disposable intravenous products market?
Key challenges include stringent regulatory requirements, increasing environmental concerns over single-use plastics, and fluctuating raw material prices that impact manufacturing costs.
Which regions are expected to have the highest demand for disposable intravenous products?
Demand is typically highest in regions with advanced healthcare systems, growing patient populations, and increasing adoption of disposable medical devices to reduce infection risks.
